Leslie Kreis
Fortune : 344 216 $ au 31/05/2026
Fortune : 344 216 $ au 31/05/2026
Leslie W.
Kreis is the founder of BIOS Capital Management LP, serving as Managing Partner since 2015.
Mr. Kreis is the founder of BIOS Equity Partners LP, serving as Managing Partner since 2015.
Mr. Kreis is the founder of BIOS Equity Partners II LP, serving as Managing Partner since 2015.
Mr. Kreis is a Managing Principal at Steelhead Capital Management LLC since 2008.
Former positions include Independent Director at Lantern Pharma, Inc. from 2019 to 2022, Independent Director at Actuate Therapeutics, Inc. from 2015 to 2024, Vice President at HBK Investments LP, and Member at Cowtown Angels.
Education includes an undergraduate degree from Texas Christian University, conferred in 1994.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/06/2025 | 170 404 ( 0,71% ) | 344 216 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
BIOS Equity Partners LP
BIOS Equity Partners LP Investment ManagersFinance Functions as private equity firm | Fondateur | 01/06/2015 |
BIOS Equity Partners II LP
BIOS Equity Partners II LP Financial ConglomeratesFinance Provides investment services | Fondateur | 01/06/2015 |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Fondateur | 01/06/2015 |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 01/01/2008 |
| Sociétés | Poste | Fin |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 14/08/2024 |
| LANTERN PHARMA INC. | Directeur/Membre du Conseil | 08/06/2022 |
HBK Investments LP
HBK Investments LP Investment ManagersFinance HBK seeks to generate superior risk-adjusted rates of return with relatively low volatility and with relatively low correlation to most major market indices. The firm may invest through both long and short positions in an unlimited range of securities, derivatives and other financial instruments throughout the world. They are not subject to any specific restrictions on asset type, industry, geographic market, concentration, and leverage, exposure to market risk or other portfolio characteristics. | Corporate Officer/Principal | - |
Cowtown Angels
Cowtown Angels Investment ManagersFinance Cowtown Angels invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed and early stage transactions. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
HBK Investments LP
HBK Investments LP Investment ManagersFinance HBK seeks to generate superior risk-adjusted rates of return with relatively low volatility and with relatively low correlation to most major market indices. The firm may invest through both long and short positions in an unlimited range of securities, derivatives and other financial instruments throughout the world. They are not subject to any specific restrictions on asset type, industry, geographic market, concentration, and leverage, exposure to market risk or other portfolio characteristics. | Finance |
Texas Christian University
Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Cowtown Angels
Cowtown Angels Investment ManagersFinance Cowtown Angels invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in seed and early stage transactions. | Finance |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Finance |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
BIOS Equity Partners LP
BIOS Equity Partners LP Investment ManagersFinance Functions as private equity firm | Finance |
BIOS Equity Partners II LP
BIOS Equity Partners II LP Financial ConglomeratesFinance Provides investment services | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national